Severe relapses after the first infusion of natalizumab in active relapsing—remitting multiple sclerosis
Author:
Affiliation:
1. Multiple Sclerosis Centre of Veneto Region of Italy, Department of Neuroscience, University Hospital of Padova, Italy,
2. Multiple Sclerosis Centre of Veneto Region of Italy, Department of Neuroscience, University Hospital of Padova, Italy
Abstract
Publisher
SAGE Publications
Subject
Clinical Neurology,Neurology
Link
http://journals.sagepub.com/doi/pdf/10.1177/1352458509107011
Reference11 articles.
1. Prevention of experimental autoimmune encephalomyelitis by antibodies against α4βl integrin
2. A Randomized, Placebo-Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis
3. Progressive Multifocal Leukoencephalopathy in a Patient Treated with Natalizumab
4. Natalizumab: Immune effects and implications for therapy
5. Effects of Natalizumab Treatment on Foxp3+ T Regulatory Cells
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. BJ-2266 ameliorates experimental autoimmune encephalomyelitis through down-regulation of the JAK/STAT signaling pathway;European Journal of Immunology;2017-07-26
2. BJ-1108, a 6-Amino-2,4,5-trimethylpyridin-3-ol analogue, regulates differentiation of Th1 and Th17 cells to ameliorate experimental autoimmune encephalomyelitis;Biological Research;2017-02-28
3. Massive exacerbation of multiple sclerosis after withdrawal and early restart of treatment with natalizumab;Journal of Clinical Neuroscience;2015-02
4. Immune reconstitution inflammatory syndrome and natalizumab–Is it possible before removing the drug?;Multiple Sclerosis and Related Disorders;2014-09
5. Targeting cells in motion: Migrating toward improved therapies;European Journal of Immunology;2013-05-13
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3